Related Experiment Videos
[Erectile dysfunction. Epidemiology, physiology, etiology, diagnosis and therapy]
H Derouet1, J Osterhage, H Sittinger
1Urologische Universitätsklinik, 66421 Homburg/Saar, Germany. DRDEROUET@aol.com
Der Urologe. Ausg. A
|March 3, 2004
Summary
Erectile dysfunction (ED) is common and age-dependent. Oral PDE-5 inhibitors are the most effective treatment, with local therapies, vacuum devices, and surgery as alternatives.
Area of Science:
- Urology
- Andrology
- Men's Health
Context:
- Erectile dysfunction (ED) is a prevalent condition, often linked to aging and comorbidities.
- Neurological and psychiatric evaluations are crucial for specific ED etiologies.
- ED management requires an interdisciplinary approach.
Purpose:
- To outline the diagnostic and therapeutic landscape of erectile dysfunction.
- To compare the efficacy of various ED treatment modalities.
- To emphasize the importance of tailored treatment strategies.
Summary:
- Oral pharmacotherapy, particularly phosphodiesterase type 5 (PDE-5) inhibitors (sildenafil, tadalafil, vardenafil), represents the most effective and preferred treatment for ED.
- Centrally acting drugs like apomorphine and yohimbine show less efficacy compared to oral PDE-5 inhibitors.
- Second-line treatments include local pharmacotherapy (MUSE, ICI), vacuum therapy, and penile implants for cases unresponsive or contraindicated to oral therapies.
Impact:
- Provides a comprehensive overview of current ED treatment options.
- Highlights the superiority of oral PDE-5 inhibitors in ED management.
- Guides clinicians in selecting appropriate therapeutic strategies based on patient factors and treatment effectiveness.